My primary focus is on exploring novel therapeutic targets and conducting in-depth investigations into the mechanisms contributing to resistance in anti-cancer therapy. Specifically, my research aims to enhance the understanding of BRCA-mutated breast cancer by investigating new treatment options and innovative strategies to improve treatment approaches. With over 15 years of practical experience in oncology, I have spent a decade actively involved as a principal investigator and subinvestigator in clinical trials. My expertise encompasses the treatment of various solid malignancies, with a particular emphasis on breast, ovarian, lung, and gastrointestinal cancers.